APA

Lechapt-Zalcman E., Levallet G., Dugué A. E., Vital A., Diebold M., Menei P., Colin P., Peruzzy P., Emery E., Bernaudin M., Chapon F. & Guillamo J. (20121119). O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide. : Cancer.

Chicago

Lechapt-Zalcman Emmanuèle, Levallet Guénaëlle, Dugué Audrey Emmanuelle, Vital Anne, Diebold Marie-Danièle, Menei Philippe, Colin Philippe, Peruzzy Philippe, Emery Evelyne, Bernaudin Myriam, Chapon Françoise and Guillamo Jean-Sébastien. 20121119. O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide. : Cancer.

Harvard

Lechapt-Zalcman E., Levallet G., Dugué A. E., Vital A., Diebold M., Menei P., Colin P., Peruzzy P., Emery E., Bernaudin M., Chapon F. and Guillamo J. (20121119). O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide. : Cancer.

MLA

Lechapt-Zalcman Emmanuèle, Levallet Guénaëlle, Dugué Audrey Emmanuelle, Vital Anne, Diebold Marie-Danièle, Menei Philippe, Colin Philippe, Peruzzy Philippe, Emery Evelyne, Bernaudin Myriam, Chapon Françoise and Guillamo Jean-Sébastien. O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide. : Cancer. 20121119.